Merus NV at Citi Virtual Oncology Leadership Summit Transcript
Okay, awesome. This is Yigal Nochomovitz. I'm one of the biotech analysts here at Citi. This is the third and final day of our Virtual Oncology Leadership Summit. And we're starting off the day with Bill Lundberg, he's the CEO of Merus. Bill, welcome. Thank you so much for taking the time to chat with us for an hour.
I think a lot of people obviously are very familiar with you guys and what you're doing. But nonetheless, it would be helpful to level set and maybe just give a quick two to three minute overview of the pipeline. Perhaps mention just some of the key catalysts coming up and maybe a word or two, just on how your technology platform is different from some of your peers developing bispecifics. Thanks.
Thank you, Yigal. Thanks to the entire Citi team and thanks for the opportunity to speak and the continued support you provided Merus. This is a really exciting time for our company. We're an oncology-focused company
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |